Gene: FGF12
Official Full Name: fibroblast growth factor 12provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This growth factor lacks the N-terminal signal sequence present in most of the FGF family members, but it contains clusters of basic residues that have been demonstrated to act as a nuclear localization signal. When transfected into mammalian cells, this protein accumulated in the nucleus, but was not secreted. The specific function of this gene has not yet been determined. [provided by RefSeq, Dec 2019]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00351 | FGF12 Knockout cell line(H9) | Human | FGF12 | 1:6-1:8 | Negative | Online Inquiry |
KO06722 | FGF12 Knockout cell line (HeLa) | Human | FGF12 | 1:3~1:6 | Negative | Online Inquiry |
FGF12 Gene Knockout Cell Lines are genetically engineered cellular models designed to lack the functional expression of the Fibroblast Growth Factor 12 (FGF12) gene. This specific gene encodes a protein that plays a pivotal role in various cellular functions, particularly in the nervous system, where it is implicated in neuronal growth, differentiation, and synaptic plasticity. By creating knockout cell lines, researchers can effectively study the physiological and molecular role of FGF12, providing insights into its contributions to neurodevelopmental disorders and other related pathologies.
These cell lines operate through a mechanism of gene editing, predominantly utilizing CRISPR-Cas9 technology, to precisely modify the genomic location of FGF12. The resultant knockout allows for comparative studies between wild-type and knockout phenotypes, enabling researchers to elucidate the downstream signaling pathways influenced by FGF12. The availability of these cell lines proves crucial in understanding disease mechanisms, drug development, and potential therapeutic targets related to neurological conditions.
The scientific importance of FGF12 Gene Knockout Cell Lines extends into research settings, where they serve as valuable tools for interrogating the functional effects of FGF12 absence. They find applications in cellular signaling research, neurobiology, and pharmacology, providing a robust platform for testing new drugs aimed at conditions linked to FGF12 dysregulation.
Compared to alternative models, such as transient or stable overexpression systems or non-specific knockout models, FGF12 Gene Knockout Cell Lines offer a higher fidelity representation of FGF12’s role in vivo, minimizing off-target effects and maintaining the endogenous cellular environment. This precision leads to more reliable and reproducible outcomes in experimental studies, making these cell lines a superior choice for researchers focused on neurological research.
For researchers and clinicians, the FGF12 Gene Knockout Cell Lines symbolize a significant leap forward in understanding cellular mechanisms and potential therapeutic avenues for treating neurodevelopmental disorders. The continuous expertise of our company in genetic engineering and cell line development ensures that we provide high-quality, reliable products designed to accelerate scientific discovery and clinical innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.